bioRxivBioinformaticsPreprint
Combining machine learning algorithms and single-cell data to study the pathogenesis of Alzheimer's disease
Wei Cui, Liang ZhangiD, Fang-Rui Zheng, Xi Huang Li, Gui-Lin XieiD
Abstract
Extracting valuable insights from high-throughput biological data of Alzheimers disease to enhance understanding of its pathogenesis is becoming increasingly important. We engaged in a comprehensive collection and assessment of Alzheimers microarray datasets GSE5281 and GSE122063 and single-cell data from GSE157827 from the NCBI GEO database. The datasets were selected based on stringent screening criteria: a P-value of less than 0.05 and an absolute log fold change (|logFC|) greater than 1. Our methodology involved utilizing machine learning algorithms, efficiently identified characteristic genes. This was followed by an in-depth immune cell infiltration analysis of these genes, gene set enrichment analysis (GSEA) to elucidate differential pathways, and exploration of regulatory networks. Subsequently, we applied the Connectivity Map (cMap) approach for drug prediction and undertook single-cell expression analysis. The outcomes revealed that the top four characteristic genes, selected based on their accuracy, exhibited a profound correlation with the Alzheimers disease (AD) group in terms of immune infiltration levels and pathways. These genes also showed significant associations with multiple AD-related genes, enhancing the potential pathogenic mechanisms through regulatory network analysis and single-cell expression profiling. Identified three subpopulations of astrocytes in late-stage of AD Prefrontal cortex dataset. Discovering dysregulation of the expression of the AD disease-related pathway maf/nrf2 in these cell subpopulations Ultimately, we identified a potential therapeutic drug score, offering promising avenues for future Alzheimers disease treatment strategies.
- organism: human
- assay: bulk RNA-seq
- research focus: differential expression
- research focus: gene regulatory network inference
- research focus: drug response / drug discovery
- approach: machine learning (classical)
- Citations
- 1
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Prediction of Alzheimer's Disease from Single Cell Transcriptomics Using Deep Learning
Aman Kumar Srivastava, Anjali Dhall, … Gajendra P. S. Raghava·bioRxiv·Jul 7, 2023
- Data-driven discovery of cell-type-directed network-correcting combination therapy for Alzheimer's disease
Yaqiao Li, Carlota Pereda Serras, … Marina Sirota·bioRxiv·Dec 9, 2024
- Single-cell network biology characterizes cell-type gene regulation for drug repurposing and phenotype prediction in Alzheimer's disease
Chirag Gupta, Jielin Xu, … Daifeng Wang·PLoS Computational BiologyPeer-reviewed·Jul 18, 2022
- Molecular mechanism decipher of Alzheimer's disease based on single-cell RNA-seq information
Xue Jiang, Dong-Qing Wei, … Éric Gilson·bioRxiv·Nov 22, 2025
- Single-cell multiomics reveals disrupted glial gene regulatory programs in Alzheimer's disease via interpretable machine learning
Shuwen Zhang, Hongru Hu, … Yingxue Ren·bioRxiv·Mar 14, 2025
- Decoding cell-type-specific alterations in Alzheimer's disease through scRNA-seq and network analysis
Andrea Álvarez-Pérez, Lucia Prieto Santamaría, Alejandro Rodríguez‐González·Proceedings - IEEE Symposium on Computer-Based Medical SystemsPeer-reviewed·Jun 18, 2025